Skip to Content

Frequently Searched

Supported by

Putting Bispecific T-Cell Engagers into Action

Last Updated: November 20, 2025

A guide for operationalizing BTCEs in your practice.

Download PDF Here

Find Similar Resources:

Immunotherapy
Immunotherapy

Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)

Last Updated: 04/23/2026
 Immunotherapy

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Last Updated: 07/01/2025
 Immunotherapy

Up Close with Linvoseltamab

Last Updated: 05/16/2025
PQI

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

Last Updated: 05/15/2026
 Patient Education Sheet

Cyclophosphamide, Bortezomib, and Dexamethasone

Last Updated: 05/12/2026
 Patient Education Sheet

Tacrolimus

Last Updated: 05/11/2026
 Patient Education Sheet

Pembrolizumab and Paclitaxel

Last Updated: 05/11/2026
Last Updated: 05/16/2026